Recently added publications
Cytomegalovirus and Epstein-Barr virus infections among pediatric kidney transplant recipients at a center using universal Valganciclovir Prophylaxis.
Author(s): Paulsen G, Cumagun P, Mixon E, Fowler K, Feig D, Shimamura M
Source: Pediatr Transplant 2019 Feb 20;:e13382
Publication date: 2019-02-20
European Society of Pediatric Nephrology survey on current practice regarding recurrent focal segmental glomerulosclerosis after pediatric kidney transplantation.
Author(s): Bouts A, Veltkamp F, Tönshoff B, Vivarelli M
Source: Pediatr Transplant 2019 Mar 1;:e13385
Publication date: 2019-03-1
Severe, persistent neurotoxicity after transplant-associated thrombotic microangiopathy in a pediatric patient despite treatment with eculizumab.
Author(s): Schoettler M, Duncan C, Lehmann L
Source: Pediatr Transplant 2019 Mar 3;:e13381
Publication date: 2019-03-3
A donor risk index for graft loss in pediatric living donor kidney transplantation.
Author(s): Wasik H, Pruette C, Ruebner R, McAdams-DeMarco M, Zhou S, Neu A, Segev D, Massie A
Source: Am J Transplant 2019 Mar 15;
Publication date: 2019-03-15
A breakthrough in readthrough? Could geneticin lead the way to effective treatment for cystinosis nonsense mutations?
Author(s): Midgley J
Source: Pediatr Nephrol 2019 Jan 8;
Publication date: 2019-01-8